SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Advertisement regarding Notice of 34th Annual General Meeting of the company, Book Closure and E-Voting information12-07-2023
12-07-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report FY 2022-2311-07-2023
SUVEN LIFE SCIENCES LTD. - 530239 - 34Th Annual General Meeting Will Be Held On Saturday, August 05Th, 2023 At 11:30 A.M. IST, Through Video Conference (VC)
Notice of 34th Annual General Meeting11-07-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Reg. 34 (1) Annual Report.
please find enclosed herewith the Notice of the 34th Annual General Meeting of the Members of the Company and the Annual Report for the Financial Year 2022-23 which is simultaneously circulated to the shareholders through electronic mode. The 34th Annual General Meeting will be held on Saturday, August 05th, 2023 at 11:30 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM). The Notice and Annual Report will also be hosted on the Company's website at: http://www.suven.com/annualreports.aspx.11-07-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Advertisement - Information regarding the 34th Annual General Meeting to be held through video conference (VC)/ other Audio Visual Means (OVAM).07-07-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended June 30, 2023, as required under Regulation 74(5) of SEBI(Depositories and Participants) Regulations, 2018, have been furnished by Kfin Technologies Limited, Registrar & Transfer Agent (RTA) of the company to stock exchanges where the shares of the company are listed. Letters confirming this from Kfin Technologies Limited dated July 5th 2023 are enclosed for your reference.06-07-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window
We wish to inform that the "Trading Window" for dealing in the securities of the company will be closed for the Designated Persons, their immediate relatives covered under the said code of the Company from 1st July 2023 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending 30th June 2023, to the public, in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations, 2015.30-06-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
With reference to above mentioned subject, we wish to inform that the Company has received intimation from the RTA (Registrar & Share Transfer Agent) i.e. Kfin Technologies Limited regarding issuance of 'Letter(s) of Confirmation' to shareholder in lieu of share certificate reported as lost by them, details are as per letter attached below.09-06-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
With reference to above subject, please find enclosed News Release of our company titled 'Suven Life Sciences completed enrollment of patients to the phase-2, Proof of Concept (PoC) clinical study of samelisant (SUVN-G3031) for the treatment of narcolepsy with or without cataplexy in USA and Canada' This is for your information and record.01-06-2023
SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Reg.24(A)-Annual Secretarial Compliance
With reference to above subject, please find enclosed herewith the Annual Secretarial Compliance Report of the Company from M/s. D. Renuka, Practicing Company Secretary, for the Financial Year ended 31st March, 2023, in terms of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th February, 2019.24-05-2023